Arnebia hispidissima

Arnebia hispidissima · Accepted scientific name

Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆

Arnebia hispidissima is a remarkable medicinal plant widely recognized for its unique phytochemical profile. The plant's therapeutic potential is primarily concentrated within its specialized root structures. Scientific investigations often utilize an ethanolic extract to effectively isolate its most potent bioactive compounds. These chemical constituents include important substances such as arnebinone, flavonoids, and acetyl shikonin. Consequently, understanding these specific components is essential for exploring the plant's diverse pharmacological applications.

Quick facts
Synonyms
Lithospermum Hispidissimum · Lithospermum Vestitum · 9 more
Common names
Not available
Family
Boraginaceae
Distribution
Asia-Temperate
Plant Parts
Root

Classification

Common Names

Arnebia hispidissima is a versatile plant known by a wide variety of regional names across different languages. In English-speaking areas, it is frequently referred to as the Arabian-primrose or the prophet flower. Its identity is also recognized in Cyrillic script as Арнебия щетинистейшая. For those using Hebrew, the species is identified as ארנבית זיפנית. These diverse common names highlight the plant's widespread recognition throughout various global cultures.

Sources: Catalogue of Life (COL)

Synonyms

Arnebia hispidissima is a botanical subject characterized by a complex web of taxonomic synonyms. In various scientific records, this species has been identified under the name Anchusa asperrima. It is also frequently referred to as Arnebia asperrima or Arnebia lutea in different botanical contexts. Furthermore, historical classifications have linked it to the name Arnebiola migiurtina. Finally, the plant has even been associated with the synonym Dioclea hispidissima, reflecting the evolving nature of its nomenclature.

Sources: The World Checklist of Vascular Plants (WCVP)

Taxonomy

Arnebia hispidissima is a fascinating botanical specimen belonging to the kingdom Plantae. Within this vast kingdom, it is classified under the class Equisetopsida. The plant specifically falls under the order Boraginales, reflecting its distinct evolutionary lineage. It is further categorized into the family Boraginaceae, which highlights its shared characteristics with related species. Ultimately, this plant is a prominent member of the genus Arnebia.

Rank Classification
Kingdom Plantae
Phylum Streptophyta
Class Equisetopsida
Subclass Magnoliidae
Order Boraginales
Family Boraginaceae
Genus Arnebia

Sources: The World Checklist of Vascular Plants (WCVP)

Distribution

Geographic Regions

Arnebia hispidissima is a plant species with a specific geographic range concentrated within the Northeast Tropical Africa region. Its distribution spans several distinct territories, including the nations of Chad, Djibouti, Eritrea, and Ethiopia. Beyond the mainland, this species also makes its presence known on the island of Socotra. This widespread presence across Northeast Africa highlights its ability to thrive in diverse local environments. Understanding these specific locations is essential for studying the ecological niche of the plant.

Sources: The World Checklist of Vascular Plants (WCVP)

Identification

Morphology

Arnebia hispidula is a self-supporting herb that maintains a compact presence in its natural habitat. This botanical species reaches a modest maximum height of only 0.4 meters. Its low-growing form makes it a subtle yet resilient addition to any collection of herbaceous plants.

Sources: Global Inventory of Floras and Traits (GIFT)

Biological Activities

Compounds

Arnebia hispidissima is a chemically diverse plant species that serves as a rich source of various bioactive compounds. Research has demonstrated that the plant contains important phytochemicals, including flavonoids, which act as stabilizing agents in nanoparticle biosynthesis. Detailed chromatographic analysis of its ethanolic extract has also identified several specific shikonin derivatives. Notably, the plant contains arnebinone, a compound shown to significantly inhibit paw edema and suppress chronic arthritis. Furthermore, the presence of acetyl shikonin highlights the complex chemical profile that contributes to the plant's therapeutic potential.

Conditions

Arnebia hispidissima demonstrates significant therapeutic potential through its ability to treat complete Freund's adjuvant (CFA)-induced chronic arthritis. Research shows that specific derivatives like arnebinone and arnebin-1 effectively suppress the development of this chronic condition. Furthermore, the plant possesses properties that treat carrageenan-induced acute arthritis, as evidenced by the inhibitory effects of compounds such as cycloarnebin-7. The extracts also serve to treat carrageenan-induced paw edema, with arnebinone playing a key role in significantly inhibiting this swelling. Collectively, these findings highlight the plant's multifaceted efficacy in managing various inflammatory models.

Preparations

Arnebia hispidissima is prepared as an ethanolic extract to facilitate the isolation of various bioactive compounds. Through the process of chromatography, this specific extract yields several important shikonin derivatives. These identified substances include arnebin-5, arnebin-6, teracryl shikonin, arnebinone, and acetyl shikonin. The research evaluates the anti-inflammatory properties of both the crude ethanolic extract and these isolated derivatives. Ultimately, the preparation of this extract allows for the study of how compounds like arnebinone can inhibit paw edema and suppress chronic arthritis.

Parts used

Arnebia hispidissima offers significant scientific potential through the utilization of its aqueous root extract for advanced biotechnological applications. Researchers have successfully employed this specific plant part to facilitate the biosynthesis of stable, crystalline silver nanoparticles. The organic compounds found within the root, such as phenolics and flavonoids, serve as essential reducing and stabilizing agents during the synthesis process. These resulting nanoparticles demonstrate remarkable bioefficacy, including potent antioxidant properties and targeted cytotoxicity against HeLa cancer cells. Furthermore, the extract-derived nanoparticles exhibit strong antimicrobial activity against a wide range of bacterial and fungal strains.